BioSpace News Archive

Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will participate at several conferences in April 2023.

Aadi Bioscience, Inc. (NASDAQ: AADI) today announced that it will present three posters at the American Association for Cancer Research Annual Meeting (AACR) 2023, taking place April 14-19, 2023, in Orlando, FL.

Moderna, Inc. and Merck announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, has been granted Priority Medicines scheme designation by the European Medicines Agency for the adjuvant treatment of patients with high-risk stage III/IV melanoma following complete resection.

AnPac Bio-Medical Science Co., Ltd. announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares, pre-funded warrants to purchase ADSs and warrants to purchase ADSs.

Luxna Biotech Co., Ltd. (President & CEO: Hideaki Sato, Headquarters: Suita-shi, Osaka, Japan, hereinafter “Luxna”) today announced that it has entered into a collaboration agreement with Servier, a global pharmaceutical group, (President: Olivier Laureau, Headquarters: Suresnes, France, hereinafter “Servier”) for drug discovery research in the field of neurological diseases.

Somatus will deliver a presentation entitled “A United Front – Serving the Underserved Together” at the National Kidney (NKF) Foundation Spring Clinical Conference.

TTG Imaging Solutions, LLC a leader in nuclear medicine and molecular imaging equipment sales and service, and the largest U.S. sales & service partner for Medical Imaging Electronics’ ANCORIS is pleased to announce the first U.S. installation of the ANCORIS, at the California Heart and Vascular Clinic in El Centro, California.

AnaptysBio, Inc., a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced the appointment of Rita Jain, M.D., to the company’s Board of Directors, effective immediately.

BD, a leading global medical technology company, announced that it will report financial results for its second quarter of fiscal year 2023 on Thursday, May 4, 2023.

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023.